1110 related articles for article (PubMed ID: 17070117)
21. Saliva analysis by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF/MS): from sample collection to data analysis.
Papale M; Pedicillo MC; Di Paolo S; Thatcher BJ; Lo Muzio L; Bufo P; Rocchetti MT; Centra M; Ranieri E; Gesualdo L
Clin Chem Lab Med; 2008; 46(1):89-99. PubMed ID: 18020972
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of an on-target sample preparation system for matrix-assisted laser desorption/ionization time-of-flight mass spectrometry in conjunction with normal-flow peptide high-performance liquid chromatography for peptide mass fingerprint analyses.
McComb ME; Perlman DH; Huang H; Costello CE
Rapid Commun Mass Spectrom; 2007; 21(1):44-58. PubMed ID: 17133622
[TBL] [Abstract][Full Text] [Related]
23. [Proteomic profiling: the potential of Seldi-Tof for the identification of new cancer biomarkers].
Solassol J; Marin P; Maudelonde T; Mangé A
Bull Cancer; 2005 Sep; 92(9):763-8. PubMed ID: 16203265
[TBL] [Abstract][Full Text] [Related]
24. Proteomic analysis of dunning prostate cancer cell lines with variable metastatic potential using SELDI-TOF.
Gretzer MB; Chan DW; van Rootselaar CL; Rosenzweig JM; Dalrymple S; Mangold LA; Partin AW; Veltri RW
Prostate; 2004 Sep; 60(4):325-31. PubMed ID: 15264244
[TBL] [Abstract][Full Text] [Related]
25. The use of surface-enhanced laser desorption/ionization time-of-flight mass spectrometry to detect putative breast cancer markers in saliva: a feasibility study.
Streckfus CF; Bigler LR; Zwick M
J Oral Pathol Med; 2006 May; 35(5):292-300. PubMed ID: 16630293
[TBL] [Abstract][Full Text] [Related]
26. Discovery of new rheumatoid arthritis biomarkers using the surface-enhanced laser desorption/ionization time-of-flight mass spectrometry ProteinChip approach.
de Seny D; Fillet M; Meuwis MA; Geurts P; Lutteri L; Ribbens C; Bours V; Wehenkel L; Piette J; Malaise M; Merville MP
Arthritis Rheum; 2005 Dec; 52(12):3801-12. PubMed ID: 16320331
[TBL] [Abstract][Full Text] [Related]
27. Surface enhanced laser desorption/ionization profiling: New diagnostic method of HBV-related hepatocellular carcinoma.
Wu C; Wang Z; Liu L; Zhao P; Wang W; Yao D; Shi B; Lu J; Liao P; Yang Y; Zhu L
J Gastroenterol Hepatol; 2009 Jan; 24(1):55-62. PubMed ID: 18823443
[TBL] [Abstract][Full Text] [Related]
28. SELDI-TOF mass spectra: a view on sources of variation.
Dijkstra M; Vonk RJ; Jansen RC
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 847(1):12-23. PubMed ID: 17118720
[TBL] [Abstract][Full Text] [Related]
29. Mass spectrometric profiling - a diagnostic tool in fish?
Provan F; Bjørnstad A; Pampanin DM; Lyng E; Fontanillas R; Andersen OK; Koppe W; Bamber S
Mar Environ Res; 2006 Jul; 62 Suppl():S105-8. PubMed ID: 16764920
[TBL] [Abstract][Full Text] [Related]
30. Cardiovascular biomarker discovery by SELDI-TOF mass spectrometry.
Meilhac O; Delbosc S; Michel JB
Methods Mol Biol; 2007; 357():331-41. PubMed ID: 17172699
[TBL] [Abstract][Full Text] [Related]
31. A data-analytic strategy for protein biomarker discovery: profiling of high-dimensional proteomic data for cancer detection.
Yasui Y; Pepe M; Thompson ML; Adam BL; Wright GL; Qu Y; Potter JD; Winget M; Thornquist M; Feng Z
Biostatistics; 2003 Jul; 4(3):449-63. PubMed ID: 12925511
[TBL] [Abstract][Full Text] [Related]
32. Discovering clinical biomarkers of ionizing radiation exposure with serum proteomic analysis.
Ménard C; Johann D; Lowenthal M; Muanza T; Sproull M; Ross S; Gulley J; Petricoin E; Coleman CN; Whiteley G; Liotta L; Camphausen K
Cancer Res; 2006 Feb; 66(3):1844-50. PubMed ID: 16452246
[TBL] [Abstract][Full Text] [Related]
33. Protein profiling of post-prostatic massage urine specimens by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry to discriminate between prostate cancer and benign lesions.
Okamoto A; Yamamoto H; Imai A; Hatakeyama S; Iwabuchi I; Yoneyama T; Hashimoto Y; Koie T; Kamimura N; Mori K; Yamaya K; Ohyama C
Oncol Rep; 2009 Jan; 21(1):73-9. PubMed ID: 19082445
[TBL] [Abstract][Full Text] [Related]
34. The use of laser microdissection and SELDI-TOF MS in ovarian cancer tissue to identify protein profiles.
Cadron I; Van Gorp T; Amant F; Vergote I; Moerman P; Waelkens E; Daemen A; Van De Plas R; De Moor B; Zeillinger R
Anticancer Res; 2009 Apr; 29(4):1039-45. PubMed ID: 19414343
[TBL] [Abstract][Full Text] [Related]
35. Serum proteomics and biomarkers in hepatocellular carcinoma and chronic liver disease.
Zinkin NT; Grall F; Bhaskar K; Otu HH; Spentzos D; Kalmowitz B; Wells M; Guerrero M; Asara JM; Libermann TA; Afdhal NH
Clin Cancer Res; 2008 Jan; 14(2):470-7. PubMed ID: 18223221
[TBL] [Abstract][Full Text] [Related]
36. Diagnostic protein discovery using proteolytic peptide targeting and identification.
Koomen JM; Zhao H; Li D; Abbruzzese J; Baggerly K; Kobayashi R
Rapid Commun Mass Spectrom; 2004; 18(21):2537-48. PubMed ID: 15468157
[TBL] [Abstract][Full Text] [Related]
37. ProteoMiner™ and SELDI-TOF-MS: a robust and highly reproducible combination for biomarker discovery from whole blood serum.
Fröbel J; Hartwig S; Passlack W; Eckel J; Haas R; Czibere A; Lehr S
Arch Physiol Biochem; 2010; 116(4-5):174-80. PubMed ID: 20662595
[TBL] [Abstract][Full Text] [Related]
38. The potential biomarkers for thromboembolism detected by SELDI-TOF-MS.
Hong M; Zhang X; Hu Y; Wang H; He W; Mei H; Yu J; Guo T; Song S
Thromb Res; 2009; 123(3):556-64. PubMed ID: 18620739
[TBL] [Abstract][Full Text] [Related]
39. Improving feature detection and analysis of surface-enhanced laser desorption/ionization-time of flight mass spectra.
Carlson SM; Najmi A; Whitin JC; Cohen HJ
Proteomics; 2005 Jul; 5(11):2778-88. PubMed ID: 15986333
[TBL] [Abstract][Full Text] [Related]
40. Simultaneous and exact interval estimates for the contrast of two groups based on an extremely high dimensional variable: application to mass spec data.
Park Y; Downing SR; Kim D; Hahn WC; Li C; Kantoff PW; Wei LJ
Bioinformatics; 2007 Jun; 23(12):1451-8. PubMed ID: 17459967
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
